(54) explored the role of TTFields in reinvigorating immune response, and demonstrated that TTFields promotes the production of immunostimulatory and pro-inflammatory interferon type 1 cytokines in tumor cells through a cGAS/STING and AIM2 inflammatory vesicle-dependent mechanism, ultimately activating the immune system. The gene discussed is AIM2; the disease is neoplasm.